Back to search

Netherlands· NL-a757a8fbb17f

Comirnaty KP.2 3 microgram/dosis concentraat voor dispersie voor injectie

A covid-19, rna-based vaccine product containing cemivameran, registered in Netherlands by BioNTech Manufacturing GmbH. The same ATC class is registered in 11 of our 19 countries.

ATC J07BN01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedComirnaty KP.2 3 microgram/dosis conc…ATCJ07BN01REGISTER NO.NL-a757a8fbb17fPACKS LISTED1CHECKEDJune 16, 2026

Where it is registered

Covid-19, rna-based vaccine is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BN01 (covid-19, rna-based vaccine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Covid-19, rna-based vaccine · ATC J07BN01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CEMIVAMERAN
Manufacturer
BioNTech Manufacturing GmbH
Country
Netherlands (NL)
ATC code
J07BN01
ATC class
Covid-19, RNA-based vaccine
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
June 16, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/20/1528

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Covid-19, rna-based vaccine in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All covid-19, rna-based vaccine products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Comirnaty Kp.2
  • Liechtenstein · Comirnaty Kp.2
  • Norway · Comirnaty Kp.2

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f69ed60e-f47c-49a5-84f5-1374c313507a
GET /v1/drugs/f69ed60e-f47c-49a5-84f5-1374c313507a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Dispersie voor injectie",
  "route": "Intramusculair gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/comirnaty-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Covid-19, RNA-based vaccine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp134697",
  "excipients": [
    "((4-HYDROXYBUTYL)AZAANDIYL)BIS(HEXAAN-6,1-DIYL)BIS(2-HEXYLDECANOAAT)",
    "1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE",
    "2-[(POLYETHYLEENGLYCOL)-2000]-N,N-DITETRADECYLACETAMIDE",
    "CHOLESTEROL",
    "SACCHAROSE",
    "TROMETAMOL",
    "TROMETAMOLHYDROCHLORIDE",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "CEMIVAMERAN"
  ],
  "leaflet_url": null,
  "authorised_at": "2020/12/21",
  "procedure_number": "EMEA/H/C/005735",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/20/1528",
  "additional_monitoring": "Y"
}

See everything about covid-19, rna-based vaccine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.